A novel brain-specific 25 kDa protein (p25) is phosphorylated by a Ser/Thr-Pro kinase (TPK II) from tau protein kinase fractions  by Takahashi, Miho et al.
Volume 289, number 1, 37-43 FEES 10092 
Q 1991 Federation of European Biochemical Societies 00145793/9l/S3.50 
ADONIS 0014579391008053 
September 199 1 
A novel brain-specific 25 kDa protein (~25) is phospkorylated by a 
Ser/Thr-Pro kinase (TPK II) from tau protein kinase fractions 
Miho Takahashi, Kayoko Tomizawa, Koichi Ishiguro, Kazuki Sato, Akira Omori, Showbu Sato, 
Akiko Shiratsuchi, Tsuneko Uchida and Kazutomo Imahori 
Mitsubishi Kmei Institute of .L$e Sciences, I I Minomiooyu, Mochid~. Tokyo 194, Jqan 
Received 3 June 1991; revised version received 26 June 1991 
A novel brain-specific 25 kDa protein (~25) was purified from a bovine brain extract. The protein was phosphorylated by SerTThr-Pro kinase (TPK 
II) in tau protein kinase fractions at the Ser residues of Ser-Pro sequences. Using immunoblot analysis, the protein was found only in brain extracts. 
and was most abundant in the brain regions such ascercbrum and hippocampus, but less abundant in cerebellum, medulla oblongata and olfactory 
bulb. The protein was detected in rat, bovine and human brain extracts, indicating that this protein spccificllly exists in mammalian brain tissues. 
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1, INTRODUCTION 
Tau is known as one of the microtubule-associated 
proteins (MTPs). Recently, it is reported that paired 
helical filaments accumulate in aged human brains, par- 
titularly in ones of Alzheimer’s disease. The paired heli- 
cal filaments contain phosphorylated tau [1,2]. We are 
therefore interested in the kinases which phosphorylate 
tau. 
2. MATERIALS AND METHODS 
2. I. Marcrials 
[r-“‘P]ATP was purchased from Amcrsham. Most chemicals. except 
where noted, were obtained from Sigma. 
Tau was purified from MTPs by the method of Grundkc-Iqubal et 
al. [9]. Tubulin was purified from MTPs by the method of Kumagai 
and Nishida [IO]. Protein concentrations were determined by the meth- 
od of Bradford [l l] with the reagent of Bio-Rad. Wistar rats (5 weeks 
01 age) were obtained from Sankyo Lab., and adult bovine brains from 
the Nakashibetsu preparation center, Mitsubishi Kasei Co. 
A protein kinase which phosphorylates tau (TPK), 
was partially purified from a rat brain extract and the 
phosphorylation of tau was stimulated in the presence 
of tubulin [3]. Then by the analysis of the phosphoryla- 
ted tau, the tau protein kinase fraction (TPKs) was 
found to contain a Ser/Thr-Pro kinase (TPK II) [4]. 
Recently, there have been found a few Ser/Thr-Pro ki- 
nases, which require X-Ser/Thr-Pro-X sequences as a 
minimal recognition site [5-81. The TPK II from tau 
protein kinase fractions is considered as a member of 
this enzyme family. 
During further purification of the enzyme from the 
bovine brain extract. a 25 kDa protein (~25) was de- 
tected. This protein was novel and found to be a sub- 
strate for TPK II. Antibodies of p25 were prepared and 
as a result of immunoblot analysis, ~25 was further 
found to be a brain-specific protein. 
2.2. Prepmwrion of wrious rissue exlrflcts 
Various tissues from rat and bovine brains were homogenized in 
buffer A (100 mM MES, pH 6.5.0.5 mM Mg-acetate, I mM EGTA, 
5 mM 2-mercaptoethanol, 0.1 mM phenylmethylsulfonyl l uoridc. I 
&ml pepstatin. I pdrnl leupcptin) and centrifuged at 14 000 rpm for 
I h at 4°C. The supernatants were mixed with one third volume of 
glycerol and served as tissue extracts. Human brain extracts wcrc 
kindly provided by Dr. Y. Ihara (University of Tokyo). A normal 
brain extract (an adult female) and an Alzhclmer brain extract (a 
female, 67 years old) were prepared as 20% homogenate inTris-saline. 
2.3. As.so_v /or kitrose activity 
Phosphorylation of tau was measured as described by Morofushi 
[12]. Tau (0.15-0.2 mg/ml) and the kinase were mixed in buffer A and 
the reaction was started by the addition of [y-“P]ATP (5000 Ci/mmol) 
at a final concentration of 0.1 mM at 37°C. In the case of synthetic 
peptidcs, the reaction mixture contained 100 mM Tris-HCI. pH 7.6, 
IO mM Mg-acetate, 50 PM peptidc and 100 PM [y-“PJATP (5000 
Ci/mmol) in a total volume of 50 ~1. The assay was carried out as 
described by Roskoski [13]. 
One unit of the kinase was defined as the amount of the enzyme 
required to incorporate I pmol of IZP into the substrate (tau or pep 
tide) in I min at 37°C. 
Ahhrevictriom: PBS, phosphate-buffcrcd saline; MTPs. microtubule- 
associated proteins; BSA. bovine serum albumin. 
2.4. AtuIysi.s q/‘otvhw ucicl .wpcwces of p2.5 cod digopc’plick 
.s_wlhesis 
The sequence of the amino acids of p25 was dctcrmincd by a pulse- 
Corre.<port&nce u(lrlre.v.s: M. Takahashi, Mitsubishi, Kasei Institute of liquid phase protein sequencer (Applied Biosystems 477A). Partial 
Lift Sciences. I I Minamiooya, Machida, Tokyo 194. Japan. Fax: (XI) peptidcs of ~25 were chemically synthesized by solid phase method 
427 29 1252. [l4]. using Biosearch model 9500 peptide synthesizer. 
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2.5. Prcpuration o~antibodics to p2S and IO the syheric peptides 
Partially purified ~25 (by gel filtration) was separated in SDS/ 
PAGE and was transferred onto nitrocellulose paper. A fine powder 
suspension of p25-nitrocellulose in PBS was injected into rabbit with 
adjuvant. 
The synthetic oligopeptide (F3) was covalcntly crosslinked to the 
carrier protein, keyhole limpet hemocyanin. through the cysteine resi- 
due attached to the N-terminal of the peptide. according to the method 
of Liu et al. [15]. Rabbits were immunized by multiple intramuscular 
injection of pcptide solution or p25 nitrocellulose suspension with 
Freund’s complete adjuvant. Booster immunizations were given at 
4-week intervals with the same quantity of antigens in Freund’s incom- 
plcte adjuvant. 
A monoclonal antibody of p25 was prepared with purified p25 from 
SP-Sephadcx according to the same methods as described previously 
U61. 
2.6. SDS-pal~ucr~lm~i~~c slab gel elecrrophoresis (SDS/PAGE) and 
Wesrcrn itntnunohlotting 
SDS/PAGE was carried out with a 3% stacking gel and a 12.5% 
resolving gel. Gels were stained with Coomassie brilliant blue R250 
or tD-silver stain II (Daiichi Pure Chemicals). For autoradiography, 
the gels were dried in vacuum and exposed to Kodak Omat RPI 6 film 
at -80°C. For Western immunobtntting, electrophoretic transfer onto 
nitrocellulose paper (Schleicher and Schuell) was carried out by the 
method of Tang et al. 1171. Immunodetcction employed the Vectastain 
ABC system (Vector Laboratories). 
3. RESULTS AND DISCUSSIONS 
3.1. Preparation of ~25 arid TPK II 
To prepare ~25 and TPK II, bovine brain was homo- 
genized in buffer A and the supernatant was treated with 
assembly-disassembly cycles to prepare MTPs accor- 
ding to the method of Ihara et al. [18]. After ammonium 
sulfate fractionation (0.33-0.50 saturation) of MTPs, 
phosphocellulose column chromatography (0.1-0.8 M 
NaCl linear gradient) was carried out. The tau-rich frac- 
tion was eluted with 0.3 M NaCl and the p25-rich frac- 
tion was eluted with 0.4 M NaCl in buffer A. Kinase 
activity was detected in both fractions. These fractions 
were applied on a G3000 SW gel filtration column 
(Toso Co., 7.5 x 600 mm), equilibrated with 0.5 M 
NaC1-buffer A. Both the kinase activity and ~25 were 
eluted together at the molecular mass of about 50 kDa. 
The kinase activity and ~25 were finally separated 
through SP-Sephadex column chromatography. The re- 
sults are shown in Fig. 1. The kinase was eluted at pH 
7.6 with a gradient of pH 6.6-8.5 of buffer B. Subse- 
quently, ~25 was eluted at 0.05 M NaCl with a linear 
gradient of O-O.1 M NaCl in buffer B, pH 8.5. The 
kinase fraction (Fr. 22-33) and ~25 fraction (Fr. 81-92) 
were concentrated with Y M 10 Diaflo membrane (Ami- 
con) and served as the enzyme and the substrate respec- 
tively. Before using p25 as the substrate, the protein was 
treated with trichloroacetic acid to remove contamina- 
ting kinase activity. Although another tau kinase ac- 
tivity (TPK I) was detected dround Fr. 60, ~25 was not 
phosphorylated by this kinase. 
3.2. Properties of’p25 
Although ~25 was isolated from bovine MTPs during 
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the purification of TPK, the protein did not specifically 
bind to MTPs, but was evenly detected in the tissue 
extract itself. This was confirmed by the immunoblot- 
ting method. The supernatant, after the removal of 
MTPs, contained ~25 at the same ratio to total protein 
as that in MTPs (data not shown). As a simple method 
of preparation of ~25, it was found possible to recover 
it in the supernatant by heat-treating the tissue extract, 
according to the method of tau preparation [9]. The 
amount of ~25 in bovine brain extracts was estimated 
as 0.5-l .O pg/mg (total protein) by the immunoblotting 
method. ~25 was a found to be a basic protein, with an 
isoelectric point of pH 9.9 determined by isoelectric 
focusing column chromatography at pH 3.5-10.0 with 
Ampholine (LKB-Produkter AB). The molecular mass 
of ~25 was estimated-to be about 50 kDa on gel filtra- 
tion of G 3000 SW. while the result on SDS-PAGE 
showed that the molecular mass was 25 kDa. These 
results suggest that ~25 may exist in a dimeric form. 
3.3. Distribution of p25 irl vurious rnarmtaliarl 
tissues 
The distribution of ~25 was determined in various 
tissues of mammals using monoclonal and polyclonal 
antibodies to ~25. Figure 2a shows the result of Western 
blotting with a polyclonal antibody to ~25 of various 
tissue extracts from rats. ~25 was detected only in brain 
extracts. A faint band of a larger molecular mass was 
detected in a kidney extract, but this reaction appeared 
even in the presence of excess ~25. therefore, it is not a 
~25 related protein. 
Figure 2b shows the distributions of ~25 in different 
regions of rat brains using a polyclonal antibody to F3. 
Figure 2c shows the distributions of ~25 in various re- 
gions of bovine brains using a monoclonal antibody to 
~25. These results indicated that ~25 was widely distri- 
buted in various regions of mammalian brains such as 
cerebrum and hippocampus, but was less abundant in 
the cerebellum. olfactory bulb and medulla oblongata. 
The ~25 was detected in human as well as rat and 
bovine brain extracts, as shown in Fig. 2d. The results 
indicate that this protein exists in mammalian brains. 
The only monoclonal antibody obtained from mouse 
hybridoma had no cross-reactivity with rat brain ex- 
tracts. Similarly, the monoclonal antibody from bovine 
~25 had a common epitope with that of human, but not 
of rat. The result may indicate that ~25 of various mam- 
malian brains contains both constant and variable 
amino acid regions. Polyclonal antibodies obtained 
using ~25 or synthetic partial peptides of the ~25 
showed cross-reactivity with these three mammals. 
It seemed that the amount of ~25 in Alzheimer’s dis- 
ease brain was slightly less than that in normal human 
brain extract (Fig. 2d). However, the number of samples 
are too limited to speculate the relation between the 
amount of ~25 and the aging effect. To elucidate the 
biological significance of ~25, the developmental and 
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Fig. 1. SP-Sephadex column chromatography of ~25 and TPK II. (a) The G -3000 SW fraction (7.6 ml. I .7S mg) containing p25 and the kinase 
activity was loaded onto a 2 ml SP-Sephadcx column equilibrated in buffer B (50 mM Tris-acetate, pH 6.6, containing 10% glycerol. 0.5 mM 
Mg-acetate, I mM EGTA. 0.05% Twecn 20 ( 20% glycerol, and protease inhibitors). The column was prepared through a series of washing and 
development; the first washing was with the equilibration buffer. pH 6.6, followed by a development with a linear pH gradient from pH 6.6 to 
pH 8.5 (IO ml each), the second washing with the buffer. pH 8.5 and then with a linear salt gradient. 0 to 0.1 M NaCl (20 ml each), and the final 
series of stcpwise washing with 0. I M, 0.3 M and 0.5 M N&I. Elution fractions (45 drops/tube) were collcctcd. The kinase activity was assayed 
with tau (0) as described in Section 2. (b) SDS/PAGE of SP-Sephadex eluatcs. Aliquots (6 $1) were withdrawn from each tube and subjected to 
SDS/PAGE and the gels were stained with silver stain. Fraction numbers are indicated above each lane. M, prc-stained molecular weight markers 
(BRL); S, charged sample. 
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Fig. 2. lmmunodctection of ~25 in extracts from various tissues of mammals. (a) Crude extracts were prepared from rat muscle (lane I ). kidney 
(lane 2). lung (lane 3), spleen (lane 4). thymus (lane 5). liver (lane 6). heart (lane 7). brain (lane 8). The protcins (l?Ogg) from the different tissues 
were subjected to SDS-PAGE. The separated proteins were either stained with CBB or electrotransferred onto nitrocellulosc paper followed by 
immunorcacting with a&p25 antiserum. Lane M. prc-stained molecular standard markers. (b) The tissue extracts of rat brains were prepared 
from cerebrum (lane I). hippocampus (lane 2), ccrcbcllum (lane 3). olfactory bulb (lane 4). and the rest of the brain (lane 5). These proteins (120 
pg) were subjcctcd to SDS-PAGE. The separated proteins were clectrotrausferred onto nitroccllulose paper followed by immunoreacting with rabbit 
antiserum directed against a synthetic ~25 peptide, F3. (c) The tissue extracts of bovine brains were prepared from cerebrum (anterior lane I. 
intermediate lane 2, posterior lane 3). septal area (lane 4). hippocampus (lane 5). cerebellum (lane 6) corpora quadrigcnia (lane 7). puns (lane 8). 
medulla oblongata (lane 9). These proteins (120 .~g) were separated as described in (b). and immunoreacted with anti-p25 monoclonal antibody. 
(d) Brain extracts were prepared from human (Alzhcimer’s discasc) (lanes 1.5). human (normal) (lan,s p 2.6). rat (lanes 3.7). and bovine (lanes 4.8). 
The proteins (60 ~9) of various brain extracts were separated as described in (b) and were immunorcacted with the anti-F3 antiserum (lanes l-4) 
40 
or with monoclonal antibody raised against bovine ~25 (lanes 5-8). 
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Protein 
2SkP 
25kP 
25kP 
tau 
tau 
tau 
Peptides 
name 
F3 
F5a 
F5b 
Kl 
K2 
K3 
Table I 
K, and V,,,., of synthetic peptidcs 
Ammo acid residues 
sequence 
KAIS;PTVSRLTD 
PANKTPPKSPGEPAKDKAAK 
________ =
MADSRPKPANKTPPKSPGEPAKDPAAK 
.___._W__ z. 
VAVVRTPPKSPSSAK 
._._...-z_ 
SGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPK 
SPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSASLAK 
I .oo 
0.63 
0.31 
0.56 
0.25 
0.19 
vm, .- 
(mmollh/mg) 
0.80 
2.66 
0.80 
1.29 
4.10 
I .60 
The phosphorylated serine is underlined. The common 6 amino acid sequences are marked with broken lines. 
a1 CBB stah Autsraciiogram 
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Fig. 3. Time course of phosphorylation of tau and ~25, and stimulation with tubulin. (a) Tau (I .5-2 yg) or (b) ~25 (1 ~8) were incubated with 
the kinase (0.5 unit for tau, I unil fof ~25) at 37°C for 1 min (lane I), 30 min (lane 2) I h (lane 3), 2 h (lane 4), 3 h (lane 5): lane B, incubated 
for 4 h without the enzyme; lane C, incubated for 4 h without the substrate; lane M, standard markers (Bio -Rad). (c) ~25 was incubated with 
the kinase for I h at 37°C without tubulin (lanes I ,5); with tubulin, I.3 pg (lane 2), 5.3 pg (lane 3). 10.6 ~18 (lane 4); with BSA, 2.5 ,ug (lane 6). 
IOyg (lane 7), 20 pg (lane 8). The reaction products were subjected to SDS/PAGE, and the gels were stained with CBB. The radiolabelcd products 
were rcvcaled by amoradiography. 
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3.5. Plrospho~.khtiot~ of synthetic peptides 
Three synthetic peptides (Table I) containing the Serl 
Thr-Pro sequences found in ~25 were made and shown 
to be substrates for TPK II (Fig. 4). A control peptide 
similar to peptide F3 but with the Ser-Pro changed to 
Pro-Ser was not phosphorylated. The site of phosphory- 
lation (Table I) was identified as Ser (Fig. 4b). A single 
Ser residue was phosphorylated on peptide F3. The 
identification was established by sequence analysis as 
PTH-dehydroalanine, the main product of Edman 
degradation of phosphoserine [4]. Phosphorylation sites 
in tau were found to be limited to Kl, K2 and K3 ([4] 
and Table I). The K,,, and V,,,;,, values were determined 
for all of the peptides listed in Table I. It was interesting 
to note that peptide F5 from ~25 and peptide PC1 of tau 
have six amino acid identities and had very similar K,, 
values. 
AckrloIl./~~gClllell/: W  thank MS Rika Kato for her technical assis- 
tance in pcptide synthesis. 
Fig. 4. Phosphorylation of synthetic pcptides of ~25. (a) The phos- 
phorylation of peptides by the kinasc was monitored as a function 
of time. The substrates were, 8. F3 (KAISSPTVSRLTD); 9. F4 
(KERFDPSGRGK); w, FSa (PANKTPPKSPGEPAKDKAAK): D. 
FSb (MADSRPKPANKTPPKSPGEPAKDKAAK). (b) Phospho- 
amino acids of “P-labeled peptides were hydrolyzed and analyzed with 
two-dimensional electrophoresis. First dimension. acetic acid/ formic 
acid/H?0 (78:25:897). pH 2.0 at 450 V for I h ; 2nd dimension. acetic 
acid/pyridine/H,O (50:5:945). pH 3.5. at 450 V for 3 h [19,20]. The 
radiolabeled amino acids were detected by autoradiography. The posi- 
tions of the phosphorylated amino acid standards were visualized by 
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3.4. Pltosphor_vhtio~~ of p25 and tou 
It has been reported that TPK II phosphorylates Ser 
or Thr of Ser/Thr-Pro sequences of tau [4]. Partial 
amino acid sequences of ~25 were determined and the 
results showed this to be a novel protein. The complete 
cDNA sequence will be published elsewhere. ~25 has 
two Ser-Pro sequences, one of which has six amino acids 
identical to the Kl site of tau ([4] and Table I). These 
observations suggested that p25 might also be phospho- 
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